Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Imipridone ONC206 Inhibits Tumor Growth and Improves Survival in Patient-Derived Xenograft Models of Uveal Melanoma.

Cancers·2026

Same author

Personalized targeting of BCL2 family proteins overcomes acquired resistance to BRAF-MEK inhibitors in preclinical melanoma.

Nature communications·2026

Same author

Topical resiquimod elicits systemic protection and improves anti-PD1 therapy in melanoma via priming of CD8+ T cells.

Cancer immunology research·2026

Same author

Targeting NFATc1-regulated MTHFD2 one-carbon metabolism to suppress sustained T-cell-mediated inflammation in rheumatoid arthritis.

Signal transduction and targeted therapy·2026

Same author

Melanoma-patient-derived xenograft multi-omics resource melPDomiX maps gain- and loss-of-function alterations.

Cell reports·2026

Same author

Single-cell lineage tracing maps clonal and transcriptional dynamics in melanoma metastasis.

bioRxiv : the preprint server for biology·2026

Search research articles

Related Experiment Video

Updated: May 24, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Narrowing the knowledge gaps for melanoma.

Ana Slipicevic¹, Meenhard Herlyn

¹The Wistar Institute, Philadelphia, PA, USA.

Upsala Journal of Medical Sciences

|February 21, 2012

Summary

Recent advances offer new melanoma treatments like BRAF inhibitors and ipilimumab, but don't cure the deadliest skin cancer. Further research into melanocyte transformation is crucial for developing improved therapies.

Area of Science:

Oncology
Dermatology
Cancer Biology

Background:

Cutaneous melanoma, originating from melanocytes, is the deadliest skin cancer.
Limited treatment options existed for advanced melanoma over the past 40 years.
Recent approvals of vemurafenib (BRAF inhibitor) and ipilimumab (immunostimulant) offer new therapeutic avenues.

Purpose of the Study:

To summarize key factors contributing to melanocyte transformation in melanoma.
To discuss recent advancements and technologies in melanoma research.
To identify gaps in understanding early melanoma development and progression.

Main Methods:

Review of current scientific literature on melanoma.
Analysis of recent therapeutic advances and their impact.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Related Experiment Videos

Last Updated: May 24, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

A 3D Organotypic Melanoma Spheroid Skin Model

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Discussion of emerging technologies for melanoma research.

Main Results:

New drugs like vemurafenib and ipilimumab have improved survival rates for late-stage melanoma.
Despite advances, current therapies do not provide a complete cure for melanoma.
Significant gaps remain in understanding the early stages of melanocyte transformation and disease progression.

Conclusions:

Novel therapies have extended patient survival but highlight the need for further treatment improvements.
Continued research into the complex genetic and biological mechanisms of melanoma is essential.
Emerging technologies and findings will pave the way for future melanoma therapies.